Metraipolis › archive › dc_bc917b5e93ca
Development and validation of a two-dimensional liquid chromatography method for therapeutic drug monitoring of pyrotinib in human plasma — Europe PMC PMID:41357864
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41357864
- DOI
- 10.3389/fphar.2025.1704594
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T08:41:14.693Z
- SHA-256 of the archived text
7e3491e237aad6259bf1a5c018ffa2fa197c180363075485e01f139ab8ea3925- Stable URL of this page
https://metraipolis.com/documento/dc_bc917b5e93ca
How to cite
Development and validation of a two-dimensional liquid chromatography method for therapeutic drug monitoring of pyrotinib in human plasma — Europe PMC PMID:41357864 — Europe PMC (en), https://europepmc.org/article/MED/41357864 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc917b5e93ca (Metraipolis archive dc_bc917b5e93ca, sha256 7e3491e237aad6259bf1a5c018ffa2fa197c180363075485e01f139ab8ea3925)
BibTeX
@misc{dcbc917b5e93ca,
title = {Development and validation of a two-dimensional liquid chromatography method for therapeutic drug monitoring of pyrotinib in human plasma — Europe PMC PMID:41357864},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41357864},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc917b5e93ca; sha256 7e3491e237aad6259bf1a5c018ffa2fa197c180363075485e01f139ab8ea3925},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357864. Agents can read the archived copy with the MCP tool read_document.